Pharmaceutical & Nutraceutical Raw Material Grade

Buy Lactobacillus salivarius Powder Manufacturer & Factories

Industrial-Scale Fermentation, Multi-Shield Microencapsulation, and Certified Viability (100B to 500B CFU/g) for Global Contract Formulators and Dietary Supplement Brands

cGMP, ISO 22000 & FSSC Compliant Ultra-Low Water Activity (Aw ≤ 0.12) Validated Cold-Chain Logistics
Integrated Raw Material Portfolio

Featured Bio-Active Ingredients & Synergistic Actives

Batch-Specific COA Verified | HPLC / Titration Tested
Microbiology & Strain Architecture

Industrial Lactobacillus Salivarius Powder: Technical Monograph & Strain Characteristics

A deep scientific evaluation of homofermentative lactic acid bacterium biology, bacteriocin secretion mechanics, and cryogenic stabilization for advanced formulation engineering.

500B CFU/g
Maximum Ultra-Concentrate Potency Available
≤0.12 Aw
Controlled Water Activity for Optimal Shelf Life
24 Months
Thermal Stability Guarantee at 2°C - 8°C Storage
99.8%
DNA Sequencing Genetic Purity & Strain Stability

Taxonomic Classification & Genetic Identity

Lactobacillus salivarius is a Gram-positive, non-spore-forming, homofermentative rod-shaped bacterium naturally inhabiting the human oral cavity, gastrointestinal tract, and urogenital tract. Known taxonomically under the revised classification as Ligilactobacillus salivarius, our industrial strain collections undergo rigorous 16S rRNA gene sequencing, whole-genome sequencing (WGS), and pulsed-field gel electrophoresis (PFGE) to prevent genomic drift across serial industrial inoculations.

Unlike facultative heterofermentative lactobacilli, L. salivarius homofermentatively catabolizes hexoses exclusively into L-(+)-lactic acid via the Embden-Meyerhof-Parnas pathway. This metabolic exclusivity enables high volumetric acid production, precipitous local pH drops (pH < 4.0), and rapid competitive exclusion of pathogenic colonizers.

Ligilactobacillus salivarius Homofermentative 16S rRNA Sequenced Non-GMO Certified

Bacteriocin Expression & Pathogen Inhibition Kinetics

The therapeutic and commercial efficacy of L. salivarius powder is governed by its ability to biosynthesize potent ribosomally synthesized antimicrobial peptides, primarily Salivaricin B and Salivaricin 9. These Class II bacteriocins disrupt the transmembrane electrical potential of target bacterial cells, causing cell membrane permeabilization, electrolyte leakage, and targeted bacteriolysis.

Furthermore, our cultivated strains exhibit high levels of endogenously secreted hydrogen peroxide ($H_2O_2$) and biosurfactants that actively inhibit biofilm formation by Gram-negative pathogens including Helicobacter pylori, Streptococcus mutans, Gardnerella vaginalis, and Salmonella enterica. In commercial nutraceutical and oral health formulations, this provides proven clinical validation that generic probiotic species cannot replicate.

Salivaricin B & 9 Biofilm Disruption H2O2 Production Antimicrobial Peptides
Advanced Bio-Engineering

Industrial Fermentation & Multi-Shield Lyophilization Technology

How our manufacturing factories overcome probiotic cellular attrition during high-density fermentation, downstream concentration, and extended ambient storage.

Optimized Culture Media & Turbidimetric Control

High-cell-density submerged fermentation is executed in state-of-the-art 30,000-liter sanitary stainless-steel bio-reactors. Growth media is formulated using vegetable-based peptones, purified yeast extracts, and specific prebiotic oligosaccharides, eliminating dairy, soy, or porcine allergens.

Fully automated SCADA systems monitor real-time pH regulation using gentle food-grade ammonium hydroxide or sodium hydroxide dosing, while maintaining dissolved oxygen (DO) strictly below 0.5% to eliminate oxidative cellular shock during log-phase proliferation.

Low-Shear Concentration & Cryoprotection

Cellular biomass harvesting utilizes continuous disk-stack centrifugation coupled with ceramic tangential flow filtration (TFF). By regulating hydrodynamic shear stress below critical cell-lysis thresholds, cellular membrane integrity exceeds 98.5% post-harvest.

Harvested cellular pellets are immediately homogenized with a proprietary cryoprotectant matrix consisting of trehalose, sodium erythorbate, and pharmaceutical maltodextrins. This matrix prevents intracellular ice crystal nucleation and membrane perforation during ultra-rapid liquid nitrogen blast freezing (-50°C).

Lyophilization & Micro-Moisture Barrier

Primary and secondary sublimation are conducted in automated vacuum freeze dryers under strict sublimation curves spanning 48 to 72 hours. Condenser temperatures are stabilized at -65°C with vacuum precision down to 0.05 mbar.

The resulting dry cake is finely milled inside an ISO Class 7 cleanroom under strict climate control (relative humidity ≤ 20%, temperature 18°C ± 2°C). Powder is microencapsulated with edible lipid shells or resistant maltodextrin to shield live bacteria against stomach acid (pH 1.5-2.0) and bile salt degradation.

Critical Formulation Variable: Water Activity ($A_w$) Control

Probiotic mortality during tablet compression or sachet blending is overwhelmingly driven by moisture mobility rather than total moisture content. Our manufacturing plants guarantee bulk Lactobacillus salivarius powder with an $A_w \le 0.12$ (measured at 25°C via chilled mirror dewpoint sensors), minimizing metabolic reactivation and hydrolytic lipid oxidation in finished commercial supplements.

Quality Verification & Release Testing

Industrial Batch Specifications: Bulk Lactobacillus salivarius Powder

Standard release monograph aligned with USP dietary supplement compendia, European Pharmacopoeia (EP 5.1.8), and FCC microbiological purity parameters.

Analytical Parameter Technical Specification Testing Methodology Compliance Reference
Viable Cell Count (CFU/g) 1.0 × 1011 / 2.0 × 1011 / 5.0 × 1011 CFU/g (±10%) ISO 19344 / Flow Cytometry / MRS Agar Plate USP <2021> / FCC Standard
Identification (Species & Strain) Positive for Lactobacillus salivarius 16S rDNA Sequencing / MALDI-TOF MS In-house / Strain Authenticity
Appearance & Physical State Fine, homogeneous, free-flowing powder; white to light cream Visual & Organoleptic Evaluation Internal Standard SOP
Loss on Drying (Moisture) ≤ 5.0% w/w Vacuum Oven (105°C, 4 hours) USP <731> / EP 2.2.32
Water Activity ($A_w$) ≤ 0.120 Chilled Mirror Dewpoint Hygrometer (25°C) USP <1112>
Particle Size (Mesh Pass) ≥ 95% pass through 80 Mesh (180 μm) Mechanical Sieve Shaker USP <786>
Heavy Metals (Pb, As, Cd, Hg) Pb ≤ 0.5 ppm | As ≤ 0.5 ppm | Cd ≤ 0.2 ppm | Hg ≤ 0.1 ppm ICP-MS (Inductively Coupled Plasma) USP <233> / Prop 65 Standard
Non-Lactic Bacteria / Total Plate Count ≤ 500 CFU/g (Excluding LAB) Selective Nutrient Agar USP <2021>
Yeasts and Molds ≤ 50 CFU/g Dichloran Rose Bengal Chloramphenicol (DRBC) USP <2021> / EP 2.6.12
Coliforms & Enterobacteriaceae < 10 CFU/g (Negative / g) VRBG Agar ISO 21528-2
Pathogenic Microorganisms Salmonella (Absent/25g), E. coli (Negative/10g), S. aureus (Neg/10g) PCR Enrichment / Automated VITEK® 2 USP <2022> / BAM FDA
Allergenic Cross-Contamination Dairy-free, Gluten-free, Soy-free, Vegan Grade ELISA Allergen Assay Kit EU 1169/2011 / FALCPA
Strategic Sourcing Superiority

Why Global Brands Partner with China's Premier Probiotic Fermentation Clusters

Scale, vertical integration, precision bioprocessing infrastructure, and dependable continuous supply for large-scale supplement manufacturers.

Mega-Scale Bioreactor Capacity & Cost Efficiency

Our centralized manufacturing hubs in Shaanxi and modern bio-industrial corridors deploy clustered 10,000L to 50,000L fully automated fermenters. By producing multi-metric ton probiotic batches in unified continuous campaigns, we eliminate batch-to-batch variation while dramatically decreasing unit energy and downstream processing costs.

These massive economies of scale allow us to offer tier-one pharmaceutical purity at direct manufacturing prices, empowering global contract developers to maintain competitive margins in commoditized retail markets.

Raw Upstream Material Security & Plant Extracts Synergy

Probiotic culture stabilization relies on consistent upstream inputs: pharmaceutical sugars, botanical polysaccharides, non-allergenic peptones, and protective carrier matrixes (FOS, Inulin, Resistant Dextrin, Resistant Starch). Operating adjacent to China's leading botanical extraction zones gives our bioreactors instant access to ultra-pure, traceable raw inputs.

We blend probiotic active strains with botanical extracts, enzymes, and mineral chelates under a single ISO/GMP certified roof, simplifying single-vendor auditing for multi-ingredient premixes.

End-to-End Cold-Chain Logistics & Lead Time Assurance

Live probiotic powder requires uncompromised thermal stability from manufacturing discharge to overseas warehouse arrival. Our dedicated export logistics protocols incorporate multi-layer aluminum vacuum foil pouches (0.12mm barrier), thermal insulation liners, active phase-change cooling packs, and continuous real-time USB/Bluetooth temperature data loggers.

Direct international air cargo routing through Xi'an, Beijing, and Shanghai guarantees terminal arrival in North America and Western Europe within 5 to 7 business days, accompanied by complete cold-chain transit logs.

Global Regulatory Defense

Localization Support, Regulatory Compliance, & Audit Dossiers

Navigating global food and supplement legislation with audit-ready documentation for FDA, EFSA, Health Canada, and regional authorities.

Comprehensive Quality Dossier for Brand Owners

Procuring raw probiotic active substances requires rigorous QA/QC approval before vendor onboarding. Our specialized regulatory documentation department supplies complete, auditable technical dossiers tailored to destination market requirements:

  • Batch-Specific Certificate of Analysis (COA): Validated by third-party ISO/IEC 17025 accredited labs (SGS, Eurofins, or Intertek).
  • Safety & Virulence Factor Profiles: Hemolytic assay records, antibiotic resistance profiles (EFSA AMR panel testing verifying absence of transferable resistance genes).
  • Manufacturing Flowcharts & HACCP: Critical control point documentation across fermentation, centrifugation, lyophilization, and nitrogen-flushed packaging.
  • Allergen & TSE/BSE Declarations: Absence of common allergens per EU Reg 1169/2011 and US FDA FALCPA requirements.
  • Non-Animal & Religious Certification: Authenticated HALAL (MUI, IFANCA compliant) and KOSHER Parve certified lots.

Regional Regulatory Alignment & Novel Food Pathways

Different jurisdictions classify Lactobacillus salivarius under specific dietary frameworks. Our technical sales and regulatory affairs team assists your formulation experts in aligning with localized label claims and regulatory filings:

  • United States: 21 CFR Part 111 cGMP compliance; self-affirmed GRAS (Generally Recognized as Safe) notifications and NDI guidance.
  • European Union: Listed under EFSA QPS (Qualified Presumption of Safety) roster with verified non-pathogenic safety records.
  • Canada: Registered natural health product (NHP) licensing support with Master File referencing for high-viability strains.
  • Asia-Pacific (APAC): Chinese National Standards (GB 4789.35, GB 14881) and ASEAN Harmonization guidelines for dietary supplements.
Formulation Engineering

High-Performance Industrial Application Scenarios

Versatile, high-potency carrier-adapted bulk powder for targeted delivery matrixes across pharmaceuticals, cosmetics, human supplements, and veterinary nutrition.

1. Oral Microbiome & Periodontal Dentifrices

Due to its high salivary adhesion and Salivaricin peptide release, L. salivarius is the premier active strain for chewable oral tablets, mints, sublingual films, and non-aqueous probiotic toothpastes. It selectively suppresses Streptococcus mutans and Porphyromonas gingivalis, mitigating volatile sulfur compounds (VSC) responsible for halitosis and promoting healthy enamel remineralization dynamics.

Chewable Lozenges Halitosis Reduction Non-Aqueous Toothpaste

2. Gastrointestinal Immunity & Enteric Capsules

When formulated into enteric-coated vegetarian HPMC or pullulan hard capsules, our microencapsulated powder bypasses gastric juices to colonize the ileum and colon. It supports mucosal tight-junction integrity (upregulating Claudin-1 and ZO-1 proteins), stimulates secretory IgA (sIgA) production, and suppresses inflammatory cytokines (IL-6, TNF-α) in IBD and leaky-gut therapy protocols.

Hard Gelatin / HPMC Enteric Barrier sIgA Secretion

3. Female Health & Vaginal Microflora Blends

Synergistically combined with L. rhamnosus and L. reuteri, bulk L. salivarius powder provides sustained hydrogen peroxide generation that acidifies the vaginal microenvironment to pH 3.8-4.5. This physiological pH selectively starves fungal pathogens like Candida albicans and bacterial vaginitis (BV) causative agents, making it indispensable for women's wellness supplements.

H2O2 Release pH 3.8-4.5 Defense Women's Flora Blends

4. Pediatric Sachets & Instant Dry Powders

Clinical data supports early infant microbiome seeding with non-dairy derived probiotic strains to promote atopic dermatitis mitigation and reduce colic-associated infantile discomfort. Our low-allergen, maltodextrin-buffered formulations mix effortlessly into warm baby formula, water, or milk without agglomeration or flavor alterations.

Instant Solubility Zero Flavor Residue Pediatric Sachets

5. Postbiotics & Topical Skincare Cosmeceuticals

With cosmetic beauty formulators racing to capitalize on microbiome protection, heat-inactivated L. salivarius lysate and cell-free ferment filtrates serve as powerful postbiotic raw materials. Rich in lactic acid, peptidoglycans, and teichoic acids, it strengthens the stratum corneum barrier, regulates sebum secretion, and inhibits Cutibacterium acnes.

Ferment Filtrates Anti-Acne Cosmeceuticals Skin Barrier Repair

6. Pet Supplements & Veterinary Feed Pre-Mixes

Companion animal wellness brands increasingly specify L. salivarius for canine and feline dental chews and soft treats. Its natural resilience against gastric transit helps normalize pet stools, reduce foul fecal odors caused by putrefactive clostridia, and protect against oral plaque formation without antibiotics.

Pet Dental Chews Stool Odor Control Feed Premix Stability
Market Dynamics & Emerging Science

Future Probiotic Trends: From Generic Strains to Precision Functional Bio-Actives

An industrial perspective on strain-specific IP, postbiotic stabilization, targeted metabolomics, and synbiotic engineering driving the 2026-2030 market.

Shift Towards Strain-Specific Clinical Substantiation

The global dietary supplement market is rapidly maturing beyond basic genus-species claims. Regulators and consumers demand clinical trials tied to specific strain designations (e.g., L. salivarius LS-01 or LS-33 equivalents). Brand owners sourcing bulk powder are prioritizing manufacturers that offer verifiable human clinical data demonstrating therapeutic endpoints like reduction of atopic dermatitis flare-ups, oral halitosis eradication, or competitive exclusion of gut pathogens.

Rise of Ambient-Stable Postbiotics (Tyndallized LAB)

While viable probiotics remain dominant in capsules, ambient-stable postbiotics (heat-inactivated microbial cells containing intact cellular structures and bioactive metabolites) are exploding in functional beverages, baked snacks, and gummies. Modern factories are expanding tyndallization capacity, enabling formulators to integrate L. salivarius benefits into hot-fill beverages and confectioneries without live-cell mortality concerns.

Next-Generation Synbiotic & Psychobiotic Systems

Advanced product development is coupling L. salivarius with specialized precision prebiotics (human milk oligosaccharides/HMOs, polyphenols, xylooligosaccharides/XOS) and neuroactive neurotransmitters like GABA. This multi-target approach leverages the gut-brain-microbiome axis, addressing digestive health, metabolic support, and stress management simultaneously in sophisticated combination supplements.

Commercial & Quality QA

Frequently Asked Questions for B2B Importers & Procurement Directors

Detailed technical clarity on potency guarantees, minimum order quantities (MOQ), custom carrier blending, testing verification, and storage stability.

What is the standard viable CFU count available, and how is overage accounted for?

We supply standardized industrial potencies of 100 Billion (1.0 × 1011), 200 Billion (2.0 × 1011), and ultra-concentrate 500 Billion (5.0 × 1011) CFU per gram. Every production lot is blended with an intentional +10% to +15% manufacturing overage at release. This ensures that even after international shipping and typical distributor warehouse handling, the product exceeds 100% of the declared COA label specification upon delivery.

Can you provide custom carrier diluents for specific dietary certifications?

Yes. While our standard carrier is food-grade, non-GMO, gluten-free maltodextrin, we routinely accommodate custom carrier requests including certified organic tapioca maltodextrin, organic inulin (Jerusalem artichoke or chicory root), resistant dextrin, microcrystalline cellulose (MCC), or fructooligosaccharides (FOS). We ensure carrier compatibility with non-GMO, 100% vegan, and allergen-free label declarations.

What testing methodology is utilized for batch enumeration on the Certificate of Analysis?

Enumeration is primarily conducted via ISO 19344 / IDF 232 using De Man, Rogosa, and Sharpe (MRS) agar pour plates with anaerobic incubation at 37°C ± 1°C for 48 to 72 hours. Alternatively, for high-throughput clients requiring rapid validation, flow cytometric live/dead cell differentiation (ISO 19344 method B using SYTO 24 and propidium iodide fluorescent dyes) is available upon request.

What are the minimum order quantities (MOQ) and commercial packaging standards?

Our standard commercial MOQ is 1.0 kg for pilot-scale trial evaluation, and 25 kg for full production batch pricing. Standard packaging comprises 1.0 kg or 5.0 kg heat-sealed multi-layer aluminum vacuum-barrier pouches backfilled with pharmaceutical-grade nitrogen gas to prevent residual oxygen exposure. Secondary packaging consists of 20 kg or 25 kg reinforced fiber drums with internal food-grade desiccants.

What shelf life and storage conditions are warranted?

When stored in original unopened nitrogen-sealed aluminum packaging at -18°C (frozen storage), we guarantee a 24-month stability period with viable cell loss under 5% annually. For refrigerated storage (2°C to 8°C), a 24-month shelf life is certified with typical survival exceeding 90%. Real-time and accelerated stability study data (Zone IVb conditions) are available for audit upon request.

Integrated Raw Material Portfolio

Nutraceutical, Amino Acid & Cosmetic Ingredients

Global Export Standard | Factory Direct Volume Supply